Physician profile
Bethany Wolf
NPI 1083017826
$1,973.47
in general payments reported to CMS, 2019-2025
11 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $389 · 2022: $409 · 2023: $214 · 2024: $542 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $639.93 | 2022-2025 | Airsupra |
| Genentech USA, INC. | $252.29 | 2021 | |
| Sanofi-Aventis U.S. LLC | $227.00 | 2024 | |
| Abbvie INC. | $172.46 | 2024-2025 | |
| Phadia US INC. | $136.37 | 2021 | |
| Novo Nordisk INC | $120.83 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $112.58 | 2024 | Onpattro |
| Horizon Therapeutics Plc | $110.48 | 2023 | Krystexxa |
| Inspire Medical Systems, INC. | $91.34 | 2025 | Inspire |
| Ultragenyx Pharmaceutical INC. | $89.64 | 2022 | |
| Pfizer INC. | $20.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.